Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome (Q37275486)
Jump to navigation
Jump to search
scientific article published on 05 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome |
scientific article published on 05 June 2013 |
Statements
1 reference
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome (English)
1 reference
Gianluca Caridi
1 reference
Monica Bodria
1 reference
Francesco Scolari
1 reference
Pietro Ravani
1 reference
Antonello Pani
1 reference
Corrado Murtas
1 reference
Mirco Belingheri
1 reference
Luciana Ghio
1 reference
Alessandro Ponticelli
1 reference
Chiara Siciliano
1 reference
Alessia Fornoni
1 reference
Alberto Magnasco
1 reference
Felice Sica
1 reference
Changli Wei
1 reference
Sandra Merscher-Gomez
1 reference
Xiangyu Wang
1 reference
Daniel Muruve
1 reference
Jochen Reiser
1 reference
5 June 2013
1 reference
1 reference
1025-1033
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference